It’s only fair to share… Bemfivastatin, PPD 10558, RBx 10558 cas 805241-79-6 Molecular Weight 588.67 Formula C34H37FN2O6 Bemfivastatin (PPD 10558) is an orally active, HMG-CoA Reductase (HMGCR) inhibitor, also known as Statin. Bemfivastatin enhances the activity of liver extraction. Bemfivastatin exhibits little developmental toxicity effects in pregnant rats and rabbits via daily oral doses during organogenesis …
Monthly archives: March, 2025
Umifoxolaner, ML 878
It’s only fair to share… Umifoxolaner, ML 878 CAS 2021230-37-3 Molecular Weight 643.86 Formula C26H16ClF10N3O3 umifoxolaner (ML-878) is a γ-aminobutyric acid (GABA) regulated chloride channels antagonist. Umifoxolaner is an anti-parasitic agent Animals such as mammals and birds are often susceptible to parasite infestations/infections. These parasites may be ectoparasites, such as insects, and endoparasites such as filariae and …
Bavtavirine
It’s only fair to share… Bavtavirine, CAS 1956373-71-9 C26H20N6 416.48 Benzonitrile, 4-[[4-amino-8-[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]-2-quinazolinyl]amino]- Gilead Sciences, Inc.; Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. Bavtavirine is a potent non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bavtavirine is part of highly active antitiretroviral therapy (HAART) treatment regimen. Bavtavirine can be used for HIV disease research. SCHEME PATENT WO2016105564 https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016105564&_cid=P11-M8QXHF-67832-1 A …
Uplarafenib
It’s only fair to share… Uplarafenib 1425485-87-5 494.5 g/mol Molecular Formula C22H21F3N4O4S Molecular Weight 494.487 UPLARAFENIB is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Neupharma, Inc. There are at least 400 enzymes identified as protein kinases. These enzymes catalyze the phosphorylation of target protein substrates. The …